Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Pharmaceutical Preparations × Clear all

NCT00095706 2015-09-25

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

Phase 1/2 Completed

Breast Neoplasms